In summary, our results suggest that Fgf6 overexpression ameliorates insulin resistance, improves basal oxygen consumption of mitochondria, and increases the AMPK activity of skeletal muscles, enhancing systemic glucose and lipid metabolism. This evidence concerns the gene FGF6 and Insulin resistance.